A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation

BACKGROUND: A number of models exploring the cost-effectiveness of dabigatran versus warfarin for stroke prevention in atrial fibrillation have been published. These studies found dabigatran was generally cost-effective, considering well-accepted willingness-to-pay thresholds, but estimates of the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorensen, Sonja V., Peng, Siyang, Monz, Brigitta U., Bradley-Kennedy, Carole, Kansal, Anuraag R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing AG 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691493/
https://www.ncbi.nlm.nih.gov/pubmed/23615895
http://dx.doi.org/10.1007/s40273-013-0035-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691493/
https://www.ncbi.nlm.nih.gov/pubmed/23615895
http://dx.doi.org/10.1007/s40273-013-0035-8

Ejemplares similares